BeOne Medicines (ONC) Return on Capital Employed Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 68,255.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 2,665.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 31,429.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 2,503.00 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -105.00 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 2,400.00 |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 1,805.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,805.00 |
| Dec 31, 2025 | 2,287.00 |
| Sep 30, 2025 | 2,727.00 |
| Jun 30, 2025 | 2,102.00 |
| Mar 31, 2025 | 2,089.00 |
| Dec 31, 2024 | 1,581.00 |
| Sep 30, 2024 | 647.00 |
| Jun 30, 2024 | 1,236.00 |
| Mar 31, 2024 | 999.00 |
| Dec 31, 2023 | 318.00 |
| Sep 30, 2023 | -972.00 |
| Jun 30, 2023 | -1,767.00 |
| Mar 31, 2023 | -2,123.00 |
| Dec 31, 2022 | -2,177.00 |
| Sep 30, 2022 | 1,293.00 |
| Jun 30, 2022 | 1,169.00 |
| Mar 31, 2022 | 916.00 |
| Dec 31, 2021 | 2,403.00 |
| Sep 30, 2021 | 520.00 |
| Jun 30, 2021 | 1,171.00 |
| Mar 31, 2021 | 2,218.00 |
| Dec 31, 2020 | 3,006.00 |
| Sep 30, 2020 | 1,055.00 |
| Jun 30, 2020 | -513.00 |
| Mar 31, 2020 | -959.00 |
| Dec 31, 2019 | -3,294.00 |
| Sep 30, 2019 | -2,003.00 |
| Jun 30, 2019 | -1,902.00 |
| Mar 31, 2019 | -2,622.00 |
| Dec 31, 2018 | -2,292.00 |
| Sep 30, 2018 | -2,384.00 |
| Jun 30, 2018 | 3,082.00 |
| Mar 31, 2018 | 3,068.00 |
| Dec 31, 2017 | 3,003.00 |
| Sep 30, 2017 | 4,476.00 |
| Jun 30, 2017 | -1,250.00 |
| Mar 31, 2017 | -504.00 |